On November 21, 2013, President Obama signed the HIV Organ Policy Equity (HOPE) Act, creating a legal pathway for people living with HIV to be living and deceased organ donors to patients with HIV on the wait list. The ERGOT team provided invaluable research, collaboration, and leadership in the nationwide effort to save more lives and provide HIV+ patients with a more equitable opportunity to receive a lifesaving transplant.
On March 30, 2016, Johns Hopkins University performed the first HIV-to-HIV transplant in the United States under the leadership of Dr. Dorry Segev, transplant surgeon, and Dr. Christine Durand, transplant infectious disease specialist.
With more than 100,000 people currently waiting for a life-saving transplant, expanding the donor pool is an imperative. Dr. Christine Durand and our ERGOT team lead HOPE in Action, a multi-site NIH-funded trial, bringing HOPE to every community, and studying the long-term safety and feasibility of HIV-HIV organ donation and transplantation.
Johns Hopkins Press Release
Realizing HOPE: Johns Hopkins Experts Examine the Ethics of HIV-Positive Organ Transplants
NPR Interview with Dr. Dorry Segev
HIV-Positive Organ Transplants Set To Begin At Johns Hopkins